Michael S. Brown, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,929 shares at $875.00 ($1.7M) on 2026-10-30, disclosed to the SEC on 2026-11-03.
Scheduled sale ($1.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| REGN | SELL | 2023-12-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-04-24 | $4.9M | — | Filing → |
| REGN | SELL | 2023-02-08 | $2.8M | — | Filing → |